Dialysis showdown: which blood thinner works best?
NCT ID NCT07618858
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two ways to prevent blood clots during dialysis in people with end-stage kidney disease. Twenty adults will try both methods—one using standard heparin and the other using a citrate-based approach—to see which causes less inflammation and removes waste better. The goal is to find the safest and most effective option for routine dialysis care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common gout pill shield hearts in kidney disease?
- A new drug combo may shield kidney transplant patients from a common viral threat
- Could delaying kidney implant during heart transplant reduce complications?
- Dialysis duel: does higher fluid volume or lower sodium improve patient outcomes?
- Could an arthritis drug stop a deadly skin condition?
- Pill vs. machine: which fixes acid imbalance better for dialysis patients?